The China Food and Drug Administration (CFDA) has announced new and updated regulations for medical device registration, testing and clinical trial requirements in the early days of 2018.
The U.S. Food and Drug Administration (FDA) has issued new guidelines related to the 3D printing of medical devices. FDA is now preparing for a significant wave of new technologies that are nearly certain to transform medical practice.
Pedro Pala, Clinical Trial Supply Manager, Bial, explores the implications of the new EU Clinical Trials Regulation
New technologies, therapies and medicines are emerging; this includes regenerative medicine, more personalised treatments, as well as the development of nanomedicines. The Commission is committed to monitoring scientific progress and to constantly review Community legislation in the light of new developments so as to make safe, novel treatments available to patients as early as possible.
NHS England says it is planning to accelerate the NHS’ national research strategy, “cutting bureaucracy and speeding up access to new and innovative treatments”.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.